Chemours Balance Sheet Analysis From 2010 to 2024

CC Stock

USD 26.62 0.25 0.95%

Most indicators from Chemours' financial ratios are interrelated and interconnected. However, analyzing financial ratios indicators one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of financial ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Chemours Valuation and Chemours Correlation analysis.

At present, Chemours' Enterprise Value Multiple is projected to increase significantly based on the last few years of reporting.

Most indicators from Chemours' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Chemours Valuation and Chemours Correlation analysis.

At present, Chemours' Enterprise Value Multiple is projected to increase significantly based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Gross Profit	1.4B	1.6B	1.3B	1.2B
Total Revenue	6.3B	6.8B	6.0B	5.1B

Gross Profit Total Revenue

Chemours fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Tangible Assets
Common Stock Shares Outstanding		-0.67	-0.75	-0.64	0.36	-0.63	-0.71	-0.05	-0.44	-0.79	-0.21	-0.6	-0.41	0.85	0.73	-0.46	-0.68	0.37	0.68	-0.51	-0.69	-0.52	0.26	0.61	-0.7	0.37
Total Assets	-0.67		0.79	0.83	-0.71	0.86	0.76	-0.08	0.68	0.86	0.37	0.87	0.84	-0.5	-0.91	0.86	0.63	-0.02	-0.92	0.9	0.72	0.95	-0.72	-0.64	0.76	-0.72
Other Current Liab	-0.75	0.79		0.85	-0.73	0.79	0.51	0.14	0.47	0.62	0.32	0.76	0.74	-0.5	-0.84	0.75	0.39	-0.23	-0.84	0.8	0.56	0.79	-0.67	-0.7	0.56	-0.74
Total Current Liabilities	-0.64	0.83	0.85		-0.59	0.84	0.43	0.27	0.69	0.58	0.4	0.92	0.64	-0.39	-0.89	0.66	0.63	-0.13	-0.74	0.75	0.79	0.86	-0.55	-0.68	0.52	-0.57
Total Stockholder Equity	0.36	-0.71	-0.73	-0.59		-0.82	-0.47	-0.11	-0.23	-0.54	-0.35	-0.67	-0.97	0.27	0.71	-0.96	-0.08	-0.25	0.88	-0.95	-0.33	-0.72	0.91	0.47	-0.46	0.99
Other Liab	-0.63	0.86	0.79	0.84	-0.82		0.58	0.14	0.55	0.72	0.5	0.9	0.85	-0.42	-0.89	0.87	0.58	0.1	-0.89	0.91	0.71	0.84	-0.73	-0.61	0.62	-0.8
Property Plant And Equipment Net	-0.71	0.76	0.51	0.43	-0.47	0.58		-0.22	0.31	0.97	0.02	0.47	0.6	-0.69	-0.59	0.64	0.51	0.05	-0.71	0.63	0.46	0.53	-0.36	-0.53	0.96	-0.51
Current Deferred Revenue	-0.05	-0.08	0.14	0.27	-0.11	0.14	-0.22		0.13	-0.12	0.46	0.26	-0.02	-0.01	-0.13	-0.01	0.05	0.1	0.0	0.03	0.15	-0.04	-0.09	-0.19	-0.27	-0.11
Accounts Payable	-0.44	0.68	0.47	0.69	-0.23	0.55	0.31	0.13		0.48	0.67	0.7	0.37	-0.09	-0.69	0.39	0.79	0.06	-0.5	0.46	0.73	0.71	-0.41	-0.5	0.33	-0.25
Non Current Assets Total	-0.79	0.86	0.62	0.58	-0.54	0.72	0.97	-0.12	0.48		0.24	0.65	0.67	-0.71	-0.74	0.71	0.64	0.03	-0.8	0.72	0.62	0.66	-0.48	-0.63	0.92	-0.58
Non Currrent Assets Other	-0.21	0.37	0.32	0.4	-0.35	0.5	0.02	0.46	0.67	0.24		0.6	0.36	0.01	-0.49	0.36	0.46	0.26	-0.39	0.38	0.47	0.4	-0.54	-0.41	-0.08	-0.36
Other Assets	-0.6	0.87	0.76	0.92	-0.67	0.9	0.47	0.26	0.7	0.65	0.6		0.74	-0.44	-0.93	0.76	0.65	-0.04	-0.82	0.82	0.84	0.88	-0.7	-0.66	0.48	-0.65
Long Term Debt	-0.41	0.84	0.74	0.64	-0.97	0.85	0.6	-0.02	0.37	0.67	0.36	0.74		-0.33	-0.78	1.0	0.22	0.22	-0.94	0.99	0.42	0.83	-0.92	-0.5	0.58	-0.97
Net Receivables	0.85	-0.5	-0.5	-0.39	0.27	-0.42	-0.69	-0.01	-0.09	-0.71	0.01	-0.44	-0.33		0.56	-0.37	-0.46	0.4	0.57	-0.39	-0.55	-0.31	0.16	0.39	-0.59	0.27
Good Will	0.73	-0.91	-0.84	-0.89	0.71	-0.89	-0.59	-0.13	-0.69	-0.74	-0.49	-0.93	-0.78	0.56		-0.81	-0.62	0.13	0.91	-0.86	-0.87	-0.9	0.73	0.68	-0.59	0.71
Non Current Liabilities Total	-0.46	0.86	0.75	0.66	-0.96	0.87	0.64	-0.01	0.39	0.71	0.36	0.76	1.0	-0.37	-0.81		0.27	0.21	-0.95	0.99	0.47	0.84	-0.91	-0.52	0.62	-0.96
Inventory	-0.68	0.63	0.39	0.63	-0.08	0.58	0.51	0.05	0.79	0.64	0.46	0.65	0.22	-0.46	-0.62	0.27		-0.12	-0.45	0.34	0.79	0.54	-0.12	-0.37	0.52	-0.08
Other Current Assets	0.37	-0.02	-0.23	-0.13	-0.25	0.1	0.05	0.1	0.06	0.03	0.26	-0.04	0.22	0.4	0.13	0.21	-0.12		-0.02	0.16	-0.21	-0.05	-0.16	-0.11	0.01	-0.27
Other Stockholder Equity	0.68	-0.92	-0.84	-0.74	0.88	-0.89	-0.71	0.0	-0.5	-0.8	-0.39	-0.82	-0.94	0.57	0.91	-0.95	-0.45	-0.02		-0.96	-0.62	-0.87	0.84	0.57	-0.67	0.88
Total Liab	-0.51	0.9	0.8	0.75	-0.95	0.91	0.63	0.03	0.46	0.72	0.38	0.82	0.99	-0.39	-0.86	0.99	0.34	0.16	-0.96		0.54	0.88	-0.89	-0.57	0.63	-0.94
Property Plant And Equipment Gross	-0.69	0.72	0.56	0.79	-0.33	0.71	0.46	0.15	0.73	0.62	0.47	0.84	0.42	-0.55	-0.87	0.47	0.79	-0.21	-0.62	0.54		0.68	-0.38	-0.61	0.47	-0.31
Total Current Assets	-0.52	0.95	0.79	0.86	-0.72	0.84	0.53	-0.04	0.71	0.66	0.4	0.88	0.83	-0.31	-0.9	0.84	0.54	-0.05	-0.87	0.88	0.68		-0.77	-0.57	0.57	-0.71
Short Term Debt	0.26	-0.72	-0.67	-0.55	0.91	-0.73	-0.36	-0.09	-0.41	-0.48	-0.54	-0.7	-0.92	0.16	0.73	-0.91	-0.12	-0.16	0.84	-0.89	-0.38	-0.77		0.41	-0.32	0.92
Intangible Assets	0.61	-0.64	-0.7	-0.68	0.47	-0.61	-0.53	-0.19	-0.5	-0.63	-0.41	-0.66	-0.5	0.39	0.68	-0.52	-0.37	-0.11	0.57	-0.57	-0.61	-0.57	0.41		-0.55	0.5
Property Plant Equipment	-0.7	0.76	0.56	0.52	-0.46	0.62	0.96	-0.27	0.33	0.92	-0.08	0.48	0.58	-0.59	-0.59	0.62	0.52	0.01	-0.67	0.63	0.47	0.57	-0.32	-0.55		-0.49
Net Tangible Assets	0.37	-0.72	-0.74	-0.57	0.99	-0.8	-0.51	-0.11	-0.25	-0.58	-0.36	-0.65	-0.97	0.27	0.71	-0.96	-0.08	-0.27	0.88	-0.94	-0.31	-0.71	0.92	0.5	-0.49

Click cells to compare fundamentals

Chemours Account Relationship Matchups

Chemours fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.3B	7.1B	7.6B	7.6B	8.3B	7.5B
Other Current Liab	477M	537M	668M	554M	1.2B	1.3B
Other Liab	751M	626M	707M	854M	982.1M	711.9M
Accounts Payable	923M	820M	1.2B	1.3B	1.1B	1.1B
Other Assets	292M	405M	547M	725M	833.8M	424.1M
Long Term Debt	4.0B	4.0B	3.7B	3.6B	4.0B	3.2B
Net Receivables	674M	511M	720M	626M	610M	602.4M
Inventory	1.1B	939M	1.1B	1.4B	1.4B	1.2B
Other Current Assets	81M	78M	75M	82M	66M	64.8M
Total Liab	6.6B	6.3B	6.5B	6.5B	7.5B	6.0B
Total Current Assets	2.8B	2.6B	3.3B	3.2B	3.8B	3.0B
Short Term Debt	13M	134M	78M	25M	106M	86.1M
Intangible Assets	28M	21M	14M	6M	3M	2.9M
Net Tangible Assets	515M	646M	973M	992M	892.8M	710.5M
Retained Earnings	1.2B	1.3B	1.7B	2.2B	1.8B	1.1B
Cash	943M	1.1B	1.5B	1.1B	1.8B	1.2B
Short Long Term Debt	13M	134M	21M	25M	51M	41.5M
Net Debt	3.5B	3.2B	2.5B	2.7B	2.5B	2.3B
Long Term Debt Total	4.0B	4.0B	3.7B	3.6B	3.2B	3.1B
Capital Surpluse	859M	890M	944M	1.0B	1.2B	958.4M

Pair Trading with Chemours

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.

Moving against Chemours Stock

0.64	DNMR	Danimer Scientific Financial Report 8th of May 2024	Pair Corr
0.59	ECL	Ecolab Inc Financial Report 7th of May 2024	Pair Corr
0.58	FEAM	5E Advanced Materials Financial Report 9th of May 2024	Pair Corr
0.56	CMT	Core Molding Technologies Financial Report 14th of May 2024	Pair Corr
0.51	ASH	Ashland Global Holdings Financial Report 7th of May 2024	Pair Corr

The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.

The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Chemours offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chemours' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chemours Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chemours Co Stock:

How To Invest In Chemours

Details

Is Chemours Stock a good investment?

Details

What is Chemours' Net Worth?

Details

Largest Specialty Chemicals Companies

View

Largest Basic Materials Companies

View

Check out Chemours Valuation and Chemours Correlation analysis.

Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Chemours Stock analysis

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.

	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope

Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.91)

Dividend Share

Earnings Share

(1.60)

Revenue Per Share

40.473

Quarterly Revenue Growth

0.017

The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Chemours Balance Sheet Analysis From 2010 to 2024

Chemours fundamental ratios Correlations

Chemours Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Chemours fundamental ratios Accounts

Pair Trading with Chemours

Moving against Chemours Stock

Complementary Tools for Chemours Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Long Term Debt
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Total Liab	+ 0.99	Long Term Debt
Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Assets Total	+ 0.97	Property Plant And Equipment Net
Property Plant Equipment	+ 0.96	Property Plant And Equipment Net

Net Tangible Assets	- 0.97	Long Term Debt
Long Term Debt	- 0.97	Total Stockholder Equity
Total Liab	- 0.96	Other Stockholder Equity
Net Tangible Assets	- 0.96	Non Current Liabilities Total
Non Current Liabilities Total	- 0.96	Total Stockholder Equity
Other Stockholder Equity	- 0.95	Non Current Liabilities Total